These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9506874)
1. CPH-82 (Reumacon) versus auranofin (Ridaura): a 36-week study of their respective onset of action rates in RA. Bjørneboe O; Moen F; Nygaard H; Haavik TK; Svensson B Scand J Rheumatol; 1998; 27(1):26-31. PubMed ID: 9506874 [TBL] [Abstract][Full Text] [Related]
2. A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis. Lerndal T; Svensson B Rheumatology (Oxford); 2000 Mar; 39(3):316-20. PubMed ID: 10788542 [TBL] [Abstract][Full Text] [Related]
3. CPH 82 (Reumacon) in refractory inflammatory arthritis. Gudmundsdóttir ES; Jónsson H Scand J Rheumatol; 2000; 29(5):323-5. PubMed ID: 11093600 [TBL] [Abstract][Full Text] [Related]
4. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study. Borg G; Allander E; Lund B; Berg E; Brodin U; Pettersson H; Trang L J Rheumatol; 1988 Dec; 15(12):1747-54. PubMed ID: 14552308 [TBL] [Abstract][Full Text] [Related]
5. Reumacon (CPH82) showed similar x-ray progression and clinical effects as methotrexate in a two year comparative study on patients with early rheumatoid arthritis. Svensson B; Pettersson H Scand J Rheumatol; 2003; 32(2):83-8. PubMed ID: 12737326 [TBL] [Abstract][Full Text] [Related]
7. Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study. Rao UR; Naidu MU; Kumar TR; Shobha U; Askar MA; Ahmed N; Sarada P; Venubabu K; Shantaram V; Menon GN J Rheumatol; 1995 Jul; 22(7):1235-40. PubMed ID: 7562751 [TBL] [Abstract][Full Text] [Related]
8. A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis. Vischer TL Ann Rheum Dis; 1988 Jul; 47(7):582-7. PubMed ID: 3041924 [TBL] [Abstract][Full Text] [Related]
9. Podophyllum derivatives (CPH 82) compared with placebo in the treatment of rheumatoid arthritis. Larsen A; Petersson I; Svensson B Br J Rheumatol; 1989 Apr; 28(2):124-7. PubMed ID: 2706415 [TBL] [Abstract][Full Text] [Related]
10. The moderate intestinal side effects of auranofin do not require prophylactic therapy with a bulkforming agent. Dutch Ridaura Study Group. van Beusekom HJ; van de Laar MA; Franssen MJ; van Valburg JA; Gijzel WP; Couvée JE Clin Rheumatol; 1997 Sep; 16(5):471-6. PubMed ID: 9348142 [TBL] [Abstract][Full Text] [Related]
11. Auranofin (SK&F) in early rheumatoid arthritis: results from a 24-month double-blind, placebo-controlled study. Effect on clinical and biochemical assessments. Johnsen V; Borg G; Trang LE; Berg E; Brodin U Scand J Rheumatol; 1989; 18(5):251-60. PubMed ID: 2688083 [TBL] [Abstract][Full Text] [Related]
12. Endocrine effects of the podophyllotoxine derivative drug CPH 82 (Reumacon) in patients with rheumatoid arthritis. Carlström K; Hedin PJ; Jönsson L; Lerndal T; Lien J; Weitoft T; Axelson M Scand J Rheumatol; 2000; 29(2):89-94. PubMed ID: 10777121 [TBL] [Abstract][Full Text] [Related]
13. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group. Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742 [TBL] [Abstract][Full Text] [Related]
14. Difference in pharmacological activity between CPH 82 and podophyllotoxin. Rosén B Scand J Rheumatol; 1998; 27(2):159. PubMed ID: 9572647 [No Abstract] [Full Text] [Related]
15. Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability. Baumgartner SW; Fleischmann RM; Moreland LW; Schiff MH; Markenson J; Whitmore JB J Rheumatol; 2004 Aug; 31(8):1532-7. PubMed ID: 15290731 [TBL] [Abstract][Full Text] [Related]
16. [The effect of Ridaura on cardiac function in patients with rheumatoid arthritis (based on echocardiographic data)]. Nemchinov EN; Chichasova NV; Kanevskaia MZ; Slobodina GA Revmatologiia (Mosk); 1990; (1):12-7. PubMed ID: 1974083 [TBL] [Abstract][Full Text] [Related]
17. Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial. Weinblatt ME; Kaplan H; Germain BF; Merriman RC; Solomon SD; Wall B; Anderson L; Block S; Irby R; Wolfe F Arthritis Rheum; 1990 Mar; 33(3):330-8. PubMed ID: 2180405 [TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid-like anti-inflammatory versus immunosuppressive effects of CPH 82 as a single drug therapy of moderately active rheumatoid arthritis patients. Masi AT; Chatterton RT Scand J Rheumatol; 2000; 29(2):85-8. PubMed ID: 10777120 [No Abstract] [Full Text] [Related]
19. [A multi-center double blind prospective study of ridaura in the treatment of rheumatoid arthritis]. Zhang NZ Zhonghua Nei Ke Za Zhi; 1992 Jul; 31(7):394-7, 443. PubMed ID: 1298591 [TBL] [Abstract][Full Text] [Related]
20. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.]. Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]